Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity

Significance The FUCCI reporter system allows live monitoring of the cell cycle via temporal expression of fluorescence markers of G0/1 or S/G2/M cell cycle phases. We found transient FUCCI reporter activity in naive neurons but not cell division, suggesting that the postmitotic state of neurons is rather a dynamic process of suppressing the cell cycle than a definite G0 state. Exposing neurons to amyloid-β resulted in death of the majority of neurons without cell cycle contribution. A subset of neurons that entered early stages of cell cycle and maintained this state were protected from amyloid-β-induced cell death. Consistently, we found high FUCCI reporter activity in the brains of mice that form amyloid-β through transgenic expression of the amyloid-β precursor protein. Neurons are postmitotic cells. Reactivation of the cell cycle by neurons has been reported in Alzheimer’s disease (AD) brains and models. This gave rise to the hypothesis that reentering the cell cycle renders neurons vulnerable and thus contributes to AD pathogenesis. Here, we use the fluorescent ubiquitination-based cell cycle indicator (FUCCI) technology to monitor the cell cycle in live neurons. We found transient, self-limited cell cycle reentry activity in naive neurons, suggesting that their postmitotic state is a dynamic process. Furthermore, we observed a diverse response to oligomeric amyloid-β (oAβ) challenge; neurons without cell cycle reentry activity would undergo cell death without activating the FUCCI reporter, while neurons undergoing cell cycle reentry activity at the time of the oAβ challenge could maintain and increase FUCCI reporter signal and evade cell death. Accordingly, we observed marked neuronal FUCCI positivity in the brains of human mutant Aβ precursor protein transgenic (APP23) mice together with increased neuronal expression of the endogenous cell cycle control protein geminin in the brains of 3-mo-old APP23 mice and human AD brains. Taken together, our data challenge the current view on cell cycle in neurons and AD, suggesting that pathways active during early cell cycle reentry in neurons protect from Aβ toxicity.

[1]  Erinna F. Lee,et al.  BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival , 2019, Cell Death & Disease.

[2]  M. Maffia,et al.  Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells. , 2019, American journal of physiology. Cell physiology.

[3]  Gavin D. Grant,et al.  Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI , 2018, Cell cycle.

[4]  G. Perea,et al.  Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons , 2018, Scientific Reports.

[5]  T. Verri,et al.  Responsiveness of Carnosine Homeostasis Genes in the Pancreas and Brain of Streptozotocin-Treated Mice Exposed to Dietary Carnosine , 2018, International journal of molecular sciences.

[6]  Nobuhiro Nakamura,et al.  Ubiquitin System , 2018, International journal of molecular sciences.

[7]  G. Halliday,et al.  Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. , 2018, The American journal of pathology.

[8]  G. Halliday,et al.  Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration , 2018, Neuroscience.

[9]  Atsushi Miyawaki,et al.  Genetically Encoded Tools for Optical Dissection of the Mammalian Cell Cycle. , 2017, Molecular cell.

[10]  T. Fath,et al.  Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.

[11]  Reinhard Dummer,et al.  Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure , 2017, EMBO molecular medicine.

[12]  W. Tremel,et al.  Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐Alpha , 2017, Advanced healthcare materials.

[13]  A. Ittner SITE-SPECIFIC PHOSPHORYLATION OF TAU INHIBITS AMYLOID-β TOXICITY IN ALZHEIMER’S MICE , 2016, Alzheimer's & Dementia.

[14]  Michael Z. Lin,et al.  Fluorescent indicators for simultaneous reporting of all four cell cycle phases , 2016, Nature Methods.

[15]  A. Karabay,et al.  Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. , 2016, BioFactors.

[16]  Wolfgang Weninger,et al.  Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells. , 2016, The Journal of investigative dermatology.

[17]  S. Dalton,et al.  Utilizing FUCCI reporters to understand pluripotent stem cell biology. , 2016, Methods.

[18]  K. Heese,et al.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease , 2016, Molecular Neurobiology.

[19]  Farzana Ahmed,et al.  Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids. , 2015, Journal of visualized experiments : JoVE.

[20]  G. Halliday,et al.  Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS , 2015, Acta Neuropathologica.

[21]  B. Edgar,et al.  FUCCI sensors: powerful new tools for analysis of cell proliferation , 2015, Wiley interdisciplinary reviews. Developmental biology.

[22]  J. Power,et al.  Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior , 2015, Neuropsychopharmacology.

[23]  J. Hoozemans,et al.  Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease , 2015, Acta Neuropathologica.

[24]  A. Ittner,et al.  p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease , 2014, Acta neuropathologica communications.

[25]  N. Haass,et al.  Real‐time cell cycle imaging during melanoma growth, invasion, and drug response , 2014, Pigment cell & melanoma research.

[26]  R. Medema,et al.  Transient activation of p53 in G2 phase is sufficient to induce senescence. , 2014, Molecular cell.

[27]  R. Young,et al.  D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL. , 2014, Developmental cell.

[28]  K. Ressler,et al.  AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications. , 2013, Journal of virological methods.

[29]  Dominik Fröhlich,et al.  Glial Promoter Selectivity following AAV-Delivery to the Immature Brain , 2013, PloS one.

[30]  R. Kayed,et al.  Molecular mechanisms of amyloid oligomers toxicity. , 2012, Journal of Alzheimer's disease : JAD.

[31]  R. Fisher The CDK Network: Linking Cycles of Cell Division and Gene Expression. , 2012, Genes & cancer.

[32]  M. Pallàs,et al.  Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death , 2012, Neurotoxicity Research.

[33]  Á. Almeida Regulation of APC/C-Cdh1 and Its Function in Neuronal Survival , 2012, Molecular Neurobiology.

[34]  T. Arendt Cell Cycle Activation and Aneuploid Neurons in Alzheimer's Disease , 2012, Molecular Neurobiology.

[35]  N. Ayad,et al.  The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis , 2011, Front. Oncol..

[36]  A. Karabay,et al.  Cell cycle markers have different expression and localization patterns in neuron-like PC12 cells and primary hippocampal neurons , 2011, Neuroscience Letters.

[37]  Inna Kuperstein,et al.  Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio , 2010, The EMBO journal.

[38]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[39]  Chang Zhu,et al.  Cdh1–APC is involved in the differentiation of neural stem cells into neurons , 2010, Neuroreport.

[40]  T. Arendt,et al.  Neuronal Aneuploidy in Health and Disease: A Cytomic Approach to Understand the Molecular Individuality of Neurons , 2009, International journal of molecular sciences.

[41]  Á. Almeida,et al.  Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity , 2008, The EMBO journal.

[42]  D. Colomer,et al.  Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators , 2008, Oncogene.

[43]  R. Newman,et al.  Fucci: street lights on the road to mitosis. , 2008, Chemistry and Biology.

[44]  F. Guillemot,et al.  Licensing regulators Geminin and Cdt1 identify progenitor cells of the mouse CNS in a specific phase of the cell cycle , 2007, Neuroscience.

[45]  T. Arendt,et al.  Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease , 2007, The Journal of Neuroscience.

[46]  P. Jackson Developmental neurobiology: A destructive switch for neurons , 2006, Nature.

[47]  S. Moreno,et al.  Cdh1/Hct1-APC Is Essential for the Survival of Postmitotic Neurons , 2005, The Journal of Neuroscience.

[48]  L. Ittner,et al.  The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. , 2005, Biochemistry.

[49]  P. Hinds,et al.  Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.

[50]  J. Bartek,et al.  Cell division: The heart of the cycle , 2004, Nature.

[51]  Guo-Jun Zhang,et al.  Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex , 2004, Nature.

[52]  A. Murray,et al.  Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.

[53]  Karl Herrup,et al.  Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease , 2003, The Journal of Neuroscience.

[54]  G. Krafft,et al.  In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.

[55]  Y. A. Minamishima,et al.  Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation , 2003, Oncogene.

[56]  S. Kügler,et al.  Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area , 2003, Gene Therapy.

[57]  T. Arendt,et al.  Cyclin D1 and Cyclin E Are Co‐Localized with Cyclo‐Oxygenase 2 (COX‐2) in Pyramidal Neurons in Alzheimer Disease Temporal Cortex , 2002, Journal of neuropathology and experimental neurology.

[58]  Frederick R. Cross,et al.  APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit , 2002, Nature.

[59]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[60]  M. Memo,et al.  Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? , 2001, Trends in Neurosciences.

[61]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Smith,et al.  Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. , 1999, Medical hypotheses.

[63]  K. Herrup,et al.  Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.

[64]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Smith,et al.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.

[66]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[67]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[68]  C. Lippa,et al.  Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders , 1995, Journal of neuropathology and experimental neurology.

[69]  C. Stevens,et al.  Early Transient Neuronal CyclinD1 Expression Precedes Atrophy in the Frontal Cortex of APP23 Mice , 2019 .

[70]  Loredana Spoerri,et al.  Real-Time Cell Cycle Imaging in a 3D Cell Culture Model of Melanoma. , 2017, Methods in molecular biology.

[71]  Atsushi Miyawaki,et al.  [Visualizing spatiotemporal dynamics of multicellular cell-cycle progression]. , 2012, Seikagaku. The Journal of Japanese Biochemical Society.

[72]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[73]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[74]  Jürgen Götz,et al.  Primary support cultures of hippocampal and substantia nigra neurons , 2008, Nature Protocols.

[75]  T. Arendt,et al.  Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[76]  R M Chau,et al.  [Cell cycle and apoptosis]. , 1996, Sheng li ke xue jin zhan [Progress in physiology].

[77]  W. B. Stine,et al.  Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. , 1995, Experimental neurology.

[78]  D. Dickson,et al.  Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. , 1995, The American journal of pathology.

[79]  J. H. Austin,et al.  Increased aneuploidy in Alzheimer disease. , 1979, American journal of medical genetics.